The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Proteomics Market?
The proteomics market has experienced significant expansion in recent years. Its valuation is set to increase from $39.37 billion in 2025 to $44.65 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.4%. The historical growth of this market can be ascribed to several factors, including the greater availability of funding for life sciences research, the increasing utilization of proteomics in drug discovery, the widespread availability of high-performance analytical instruments, the proliferation of academic research initiatives, and the rising demand for biomarker discovery.
The proteomics market is anticipated to experience substantial expansion in the coming years. By 2030, its value is projected to reach $73.33 billion, driven by a compound annual growth rate (CAGR) of 13.2%. This projected growth during the forecast period stems from factors such as increasing investments in precision medicine initiatives, the growing need for multi-omics analysis, the broadening scope of clinical proteomics applications, the rising uptake of AI-driven data analysis tools, and an intensified focus on disease pathway analysis. Key trends anticipated over this period encompass a greater adoption of sophisticated proteomic analysis techniques, the increasing application of mass spectrometry-based proteomics, the growing unification of proteomics with genomics data, the broadening availability of cloud-based proteomics platforms, and an elevated emphasis on quantitative proteomics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2828&type=smp
What Are The Main Drivers Accelerating The Growth Of The Proteomics Market?
The expanding pharmaceutical industry is projected to drive the growth of the proteomics market. This industry is dedicated to researching, developing, manufacturing, and distributing drugs and medications for medical applications. The pharmaceutical industry is experiencing an uptick due to the increasing global burden of chronic illnesses, which in turn elevates the demand for continuous drug development and sophisticated therapeutic solutions, thus fostering sustained market growth. Proteomics is essential in drug development for identifying, characterizing, and monitoring proteins relevant to drug targets and the discovery of biomarkers. As an illustration, in June 2023, figures from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing Europe’s pharmaceutical industry, showed that total pharmaceutical production in Europe amounted to €390,000 million ($422,803 million) in 2023, a rise from €363,300 million ($393,857 million) in 2022. Hence, the burgeoning pharmaceutical industry is propelling the proteomics market’s expansion.
What Key Segment Areas Are Included In The Proteomics Market Assessment?
The proteomics market covered in this report is segmented –
1) By Component: Reagents, Instruments, Software
2) By Instrument: Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation
3) By Type: Core Instrument Services, Proteomic Analytical Services
Subsegments:
1) By Reagents: Protein Assays, Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Electrophoresis Reagents
2) By Instruments: Mass Spectrometry, Chromatography Equipment, Electrophoresis Equipment, Microarray Instruments, X-ray Crystallography Instruments
3) By Software: Data Analysis Software, Bioinformatics Tools, Cloud-Based Platforms For Proteomics
Which Trends Are Supporting The Evolution Of The Proteomics Market?
Major companies active in the protein stability analysis market are increasingly concentrating on technological breakthroughs, such as the Veloci biopharma analyzer, to provide advanced molecular fingerprinting tools. These tools are designed to enhance the accuracy, speed, and efficiency of protein characterization and quality assessment. The Veloci biopharma analyzer is an advanced instrument that utilizes A-TEEM technology to facilitate rapid, label-free molecular fingerprinting for various life science applications, including protein stability analysis and vaccine characterization. For instance, in March 2025, Horiba Advanced Techno Co. Ltd., a Japan-based company specializing in analytical solutions and measurement equipment, launched four new analytical instruments. This launch included a biopharma analyzer featuring A-TEEM technology, a high-throughput Raman plate reader, and an advanced atomic force microscopy system, all developed to improve molecular fingerprinting, real-time reaction monitoring, and multimodal material analysis. These innovations are aimed at supporting critical applications in biopharmaceutical research, such as cell culture media analysis, vaccine development, and protein characterization.
Which Industry Players Are Present In The Proteomics Market?
Major companies operating in the proteomics market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Vproteomics, Shimadzu Corporation, Abcam plc, MRM Proteomics Inc., Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, Caprion Proteomics Inc.
Access The Complete Proteomics Market Report:
https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report
Which Region Leads The Proteomics Market By Size?
North America was the largest region in the proteomics market in 2025. Western Europe was the second largest region in the global proteomics market share. The regions covered in the proteomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Proteomics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=2828&type=smp
Browse Through More Reports Similar to the Global Proteomics Market 2026, By The Business Research Company
Therapeutic Proteins Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report
Protein Labelings Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-labelings-global-market-report
Protein Inhibitor Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
